Posted on 10/5/16
What Clinton and Trump Would Do to Medicare
Baby boomers are increasingly nervous they won't have enough money to pay for healthcare in retirement, and with Medicare straining because of rising enrollment, it's unlikely . . .
Posted on 10/5/16
CVS Stock Split History: Is Another Split Coming Soon?
IMAGE SOURCE: CVS HEALTH.The corner drugstore is an American icon, but CVS (NYSE:CVS) has turned it into a big business that spans much further than just . . .
Posted on 10/5/16
CVS Health - PBM Scrutiny Overhangs Industry
CVS Business and Investment CaseCVS Health (NYSE:CVS) boasts a history of success and strategic collection of synergistic healthcare businesses operating in an economically resilient industry. The . . .
Posted on 10/4/16
INVO Bioscience Launches New Corporate Website
INVO Bioscience, Inc. (OTC: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, INVOcell™, today announced the launch of . . .
Posted on 10/4/16
Keryx Biopharmaceuticals Is Likely To Fully Recover From August
Keryx Biopharmaceuticals (NASDAQ:KERX) is a small company (market cap: $555.82 million) focused on bringing the benefits of its sole product Auryxia to a large segment of . . .
Posted on 10/4/16
Healthcare2U Expands into the Northeast
Continuing rapid growth, Healthcare2U is expanding its network of direct primary care clinics into the Northeast.Dr. Lorenzo Galante and Dr. Sanjay K. Aggarwal, of New Haven, . . .
Posted on 10/4/16
CVS Health Recognizes its 30,000 Pharmacists during American Pharmacists Month
In recognition of October's American Pharmacists Month, CVS Health (NYSE:CVS) is celebrating the important role its nearly 30,000 pharmacists play in helping people on their path . . .
Posted on 10/4/16
Exosome Diagnostics Enters Agreement with Amgen
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exosome Diagnostics, Inc. has entered into an agreement with Amgen to evaluate the potential to advance drug development with Exosome’s proprietary liquid biopsy diagnostics . . .
Posted on 10/3/16
Merrimack Announces Major Corporate Restructuring
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced a major corporate restructuring with the objective of prioritizing its research and development
Posted on 10/3/16
Is Sarepta Therapeutics Still a Risky Bet?
IMAGE SOURCE: GETTY IMAGES.Snag a much-needed Food and Drug Administration approval? Check. Increase the company's market cap by over 120% in a matter of days? Check. . . .
Posted on 10/3/16
Hillary Clinton vs. Donald Trump on Obamacare
IMAGE SOURCE: GETTY IMAGES.In a little more than five weeks, American voters will head to the polls to determine who will lead the United States for . . .
Posted on 10/2/16
Cynosure Recognized as One of FORTUNE's 100 Fastest-Growing Companies
Cynosure, Inc. (NASDAQ: CYNO) which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today announced that it has been named . . .
Posted on 10/2/16
LEO Pharma Expands Partnering Presence with LEO Science & Tech Hub in Boston
BOSTON--(BUSINESS WIRE)--LEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin, today announced the official inauguration of the LEO Science & Tech Hub . . .
Posted on 9/30/16
ProEx Physical Therapy Appoints Melanie Bachteler as Exercise Technician and Athletic Trainer
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine announces that Melanie
Posted on 9/30/16
Bristol-Myers Squibb (BMY) Presents at Leerink Partners Rare Disease & Immuno-Oncology Roundtable Conference (Transcript)
Bristol-Myers Squibb Company (NYSE:BMY)Leerink Partners Rare Disease & Immuno-Oncology Roundtable ConferenceSeptember 29, 2016 03:00 PM ETExecutivesDr. Fouad Namouni - Oncology Development HeadAnalystsSeamus Fernandez - Leerink Swann, . . .
Posted on 9/30/16
One Biotech Crashes, the Other Skyrockets -- Here's Why
In a tale of two biotechs, Novavax (NASDAQ:NVAX) and Sarepta Therapeutics (NASDAQ:SRPT) shares couldn't have taken more divergent paths recently. As billions of dollars in projected . . .
Posted on 9/30/16
bluebird bio and Medigene Establish Strategic T Cell Receptor Alliance in Cancer Immunotherapy
MARTINSRIED/MUNICH & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Medigene AG (MDG1, Frankfurt, Prime Standard), Germany, and bluebird bio, Inc. (Nasdaq: BLUE), USA, today announced the signing of a strategic research . . .
Posted on 9/30/16
Catabasis Pharmaceuticals and Sarepta Therapeutics Announce a Joint Research Collaboration
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company (“Catabasis”), and Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage developer of innovative RNA-targeted therapeutics (“Sarepta”), today announced . . .
Posted on 9/29/16
Peak Physical Therapy & Sports Performance Adds Maria O’Laughlin as Staff Physical Therapist
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide holistic
Posted on 9/29/16
Instant Analysis: Biogen's Agreement With Anavex Life Sciences
IMAGE SOURCE: GETTY IMAGES.What happened?This morning, Anavex Life Sciences (NASDAQ:AVXL) announced an agreement withBiogen (NASDAQ:BIIB) concerning the latter's only clinical-stage candidate, Anavex 2-73. Biogen will conduct . . .
Posted on 9/29/16
Better Buy: BioMarin Pharmaceuticals Inc. vs. Sarepta Therapeutics Inc
IMAGE SOURCE: GETTYInvesting in the biotech industry is risky business. The majority of companies from the sector operate at a loss for years on end in . . .
Posted on 9/28/16
Catabasis Pharmaceuticals Closes $11.5 Million Stock Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB), a clinical-stage pharmaceutical company, today announced the closing of an underwritten offering of 2,875,000 shares of its common stock, . . .
Posted on 9/28/16
Boston BioTech Companies Support Walk for Primary Immunodeficiency
The Immune Deficiency Foundation (IDF) will be hosting the 3rd Annual IDF Walk for Primary Immunodeficiency in Boston this Sunday, October 2 thanks to the support . . .
Posted on 9/28/16
The 3 Best-Run Companies in the Healthcare Sector
IMAGE SOURCE: GETTY IMAGES.The healthcare sector is massive and poised for long-term growth, but it's also becoming increasingly more competitive. One way investors can increase their . . .
Posted on 9/28/16
X4 Pharmaceuticals Announces Initiation of Phase 1b Study of X4P-001 in Patients with Resectable Stage III and Stage IV Melanoma
Innovative biomarker study designed to study the trafficking of cancer-fighting immune cells into the tumor microenvironmentX4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 inhibitor . . .
Boston
